Has Robert Buckenberger, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $20,774 in general payments to Robert Buckenberger, DPM across 124 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Buckenberger, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Buckenberger, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Buckenberger, DPM

Podiatrist · Fresno, CANPI 1063594778

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 85.7% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $13,223, more than ten times the $47 reported in 2019. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,774in general payments, 2019–2025

Across 124 payments — averaging $167.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Treace Medical Concepts, Inc.$18K
Paragon 28, Inc.$1K
Nevro Corp.$543
Arthrex$278
Cornerstone Medical Associates, Inc.$250
Kowa Pharmaceuticals America, Inc.$182
plus $655 from 10 others

What the payments were for

Consulting fees$6,16330%
Travel & lodging$9,53046%
Food & beverage$5,08224%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Treace Medical Concepts, Inc.	57	$17,810
Paragon 28, Inc.	7	$1,055
Nevro Corp.	10	$543
Arthrex	4	$278
Cornerstone Medical Associates, Inc.	1	$250
Kowa Pharmaceuticals America, Inc.	15	$182
Smith+Nephew	14	$181
Medtronic	2	$160
Stryker	4	$156
Paratek Pharmaceuticals, Inc.	2	$37
Bioventus LLC	2	$32
Orthofix Medical, Inc.	2	$25
Alfasigma USA, Inc.	1	$20
Osiris Therapeutics Inc.	1	$17
Globus Medical	1	$14
Boston Scientific	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,774 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California →

Medicare billing

Part B allowed, 2024

$233,568

Medicare patients

819

Services billed

3,302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	360	$10,024
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort	50	$2,218
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	11	$1,215
Gabapentin	92	$646
Ciclopirox	23	$540
Terbinafine Hcl	36	$507
CiclopiroxCiclopirox Olamine	14	$303
Cephalexin	23	$302
Meloxicam	179	$253
Methylprednisolone	43	$224
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	28	$159
Silver Sulfadiazine	25	$157
Tramadol Hcl	11	$40

Paid to pharmacies, not to this prescriber.

Other podiatrist in Fresno

Emmy OjiFresno$29K
Shawn CazzellFresno$19K
Shannon RushPleasanton$1.9M
Babak BaravarianSanta Monica$1.1M
Robert KleimanCalexico$913K
Bruce LawrenceOceanside$810K
David ArmstrongLos Angeles$695K
Philip WrotslavskyPoway$269K
Travis WestermeyerEncinitas$158K
Adrienne EstesPomona$129K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →